BAO PHARMA-B (02659) schedules 26 Mar 2026 board meeting to approve FY2025 annual results

Bulletin Express03-16

Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B, stock code: 02659) has announced that its board of directors will convene on 26 March 2026 in Shanghai. The primary agenda is to review and approve the consolidated financial results for the year ended 31 December 2025 and to authorize their publication.

The current board comprises 12 directors: • Executive Directors: Dr. Liu Yanjun (Chairman), Ms. Wang Zheng, Mr. Tan Jingwei, and Ms. Li Cui • Non-executive Directors: Ms. Lin Chia-ling, Mr. Diao Juanhuan, and Mr. Li Chen • Independent Non-executive Directors: Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen, and Mr. Zhang Senquan

The company did not provide preliminary financial figures in this announcement; detailed performance metrics will be disclosed following the board’s approval of the FY2025 results later this month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113827952?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113827952","market":"hk","top_or_hot":-1,"title":"BAO PHARMA-B (02659) schedules 26 Mar 2026 board meeting to approve FY2025 annual results","media":"Bulletin Express","content":"<p>Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B, stock code: 02659) has announced that its board of directors will convene on 26 March 2026 in Shanghai. The primary agenda is to review and approve the consolidated financial results for the year ended 31 December 2025 and to authorize their publication.</p>\n<p>The current board comprises 12 directors:\n• Executive Directors: Dr. Liu Yanjun (Chairman), Ms. Wang Zheng, Mr. Tan Jingwei, and Ms. Li Cui  \n• Non-executive Directors: Ms. Lin Chia-ling, Mr. Diao Juanhuan, and Mr. Li Chen  \n• Independent Non-executive Directors: Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen, and Mr. Zhang Senquan</p>\n<p>The company did not provide preliminary financial figures in this announcement; detailed performance metrics will be disclosed following the board’s approval of the FY2025 results later this month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BAO PHARMA-B (02659) schedules 26 Mar 2026 board meeting to approve FY2025 annual results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBAO PHARMA-B (02659) schedules 26 Mar 2026 board meeting to approve FY2025 annual results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B, stock code: 02659) has announced that its board of directors will convene on 26 March 2026 in Shanghai. The primary agenda is to review and approve the consolidated financial results for the year ended 31 December 2025 and to authorize their publication.</p>\n<p>The current board comprises 12 directors:\n• Executive Directors: Dr. Liu Yanjun (Chairman), Ms. Wang Zheng, Mr. Tan Jingwei, and Ms. Li Cui  \n• Non-executive Directors: Ms. Lin Chia-ling, Mr. Diao Juanhuan, and Mr. Li Chen  \n• Independent Non-executive Directors: Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen, and Mr. Zhang Senquan</p>\n<p>The company did not provide preliminary financial figures in this announcement; detailed performance metrics will be disclosed following the board’s approval of the FY2025 results later this month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"","article_id":"1113827952","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113827952","pubTimestamp":1773650538,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B, stock code: 02659) has announced that its board of directors will convene on 26 March 2026 in Shanghai. The primary agenda is to review and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"宝药业-B(02659)定于2026年3月26日召开董事会批准2025财年全年业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B, stock code: 02659) has announced that its board of directors will convene on 26 March 2026 in Shanghai. The primary agenda is to review and approve the consolidated financial results for the year ended 31 December 2025 and to authorize their publication.\nThe current board comprises 12 directors:\n• Executive Directors: Dr. Liu Yanjun (Chairman), Ms. Wang Zheng, Mr. Tan Jingwei, and Ms. Li Cui  \n• Non-executive Directors: Ms. Lin Chia-ling, Mr. Diao Juanhuan, and Mr. Li Chen  \n• Independent Non-executive Directors: Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen, and Mr. Zhang Senquan\nThe company did not provide preliminary financial figures in this announcement; detailed performance metrics will be disclosed following the board’s approval of the FY2025 results later this month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113827952","isCrawlerRequest":true}